Cargando…

Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators

A conceptualized model may be useful for understanding risk stratification of primary prevention implantable cardioverter defibrillators considering the competing risks of appropriate implantable cardioverter defibrillator shock versus mortality. METHODS AND RESULTS—: In a prospective, multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Douglas S., Hardy, Judy, Yee, Raymond, Healey, Jeffrey S., Birnie, David, Simpson, Christopher S., Crystal, Eugene, Mangat, Iqwal, Nanthakumar, Kumaraswamy, Wang, Xuesong, Krahn, Andrew D., Dorian, Paul, Austin, Peter C., Tu, Jack V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568903/ https://www.ncbi.nlm.nih.gov/pubmed/26224792 http://dx.doi.org/10.1161/CIRCHEARTFAILURE.115.002414

Ejemplares similares

Potential clinical impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for cardioverter defibrillator implantation
por: Joshi, Subodh B, et al.
Publicado: (2012)

Myocardial strain assessment using cardiovascular magnetic resonance imaging in recipients of implantable cardioverter defibrillators
por: Tan, Nigel S., et al.
Publicado: (2021)

Impact of cardiovascular magnetic resonance assessment of ejection fraction on eligibility for implantable cardioverter defibrillators
por: Joshi, Subodh B, et al.
Publicado: (2011)

Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population‐Based Registry
por: Almehmadi, Fahad, et al.
Publicado: (2017)

Heart rate in patients with reduced ejection fraction: relationship between single time point measurement and mean heart rate on prolonged implantable cardioverter defibrillator monitoring
por: Habal, Marlena V., et al.
Publicado: (2018)

The Role of Ablation in Prevention of Recurrent Implantable Cardioverter Defibrillator Shocks in Patients With Tetralogy of Fallot
por: Kawada, Satoshi, et al.
Publicado: (2021)

Prognostic value of cardiovascular magnetic resonance left ventricular volumetry and geometry in patients receiving an implantable cardioverter defibrillator
por: Urzua Fresno, Camila M., et al.
Publicado: (2021)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Brugada Syndrome: The Role of Risk Stratification in Selecting Patients for Implantable Cardioverter-defibrillator Placement
por: Mankbadi, Michael, et al.
Publicado: (2018)

Do acute changes in ambient air pollution increase the risk of potentially fatal cardiac arrhythmias in patients with implantable cardioverter defibrillators?
por: Dales, Robert, et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Sex‐specific differences in outcome and risk stratification of ventricular arrhythmias in implantable cardioverter defibrillator patients
por: van der Lingen, Anne‐Lotte C.J., et al.
Publicado: (2021)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators
por: Singh, Sajya M., et al.
Publicado: (2021)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Correction to: Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry
por: Veltmann, Christian, et al.
Publicado: (2020)

Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice
por: Calò, Leonardo, et al.
Publicado: (2021)

Toward Better Risk Stratification for Implantable Cardioverter-Defibrillator Recipients: Implications of Explainable Machine Learning Models
por: Deng, Yu, et al.
Publicado: (2022)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter–Defibrillator in Non-Ischemic Cardiomyopathy
por: Keil, Laura, et al.
Publicado: (2021)

Higher defibrillation threshold in methamphetamine cardiomyopathy patients with implantable cardioverter-defibrillator
por: Malhotra, Rakesh, et al.
Publicado: (2017)

Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022)

Quality of Life in Patients with Implantable Cardioverter Defibrillators
por: Francis, Johnson, et al.
Publicado: (2006)

Perioperative Management of Patients with Implantable Cardioverter Defibrillators
por: Donnelly, Patrick, et al.
Publicado: (2007)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Electrical Storms in Patients with an Implantable Cardioverter Defibrillator
por: Song, Pil Sang, et al.
Publicado: (2011)

The use of implantable cardioverter defibrillators in pediatric patients
por: Campagnucci, V, et al.
Publicado: (2013)

The first cardioverter defibrillator implanted in Central Africa
por: Cabral, Tantchou Tchoumi Jacques, et al.
Publicado: (2016)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Tachycardia detection in modern implantable cardioverter–defibrillators
por: Brüggemann, Thomas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_87ea3tegu4ft7p1m67qgnut8aa